A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

著者: Olivier Rascol, Cheryl Fitzer‐Attas, Robert A. Hauser, Joseph Jankovic, Anthony E. Lang, J. William Langston, Eldad Melamed, Werner Poewe, Fabrizio Stocchi, Eduardo Tolosa, Eli Eyal, Yoni M. Weiss, C. Warren Olanow - The Lancet 2011 被引用: 212